Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 6942855 Viral vectors having reduced virulence
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
April 23, 2004
0
Date of Patent
September 13, 2005
0
Patent Application Number
10830547
0
Patent Citations Received
US Patent 11884939 Vaccinia virus mutants useful for cancer immunotherapy
0
US Patent 11986503 Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy
0
Patent Inventor Names
Bertram Jacobs
0
Jeffrey Langland
0
Sangeetha Vijaysri
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
6942855
0
Patent Primary Examiner
David Guzo
0
Find more entities like US Patent 6942855 Viral vectors having reduced virulence
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE